HIV drug resistance in African infants and young children newly diagnosed with HIV: a multicounty analysis (Q41919022)

14 October 2017

title

HIV drug resistance in African infants and young children newly diagnosed with HIV: a multicounty analysis (English)

1 reference

Sekesai Mtapuri-Zinyowera

14 October 2017

1 reference

13

Sekesai Mtapuri-Zinyowera

0 references

Ilesh V Jani

Ilesh Jani

5

0 references

Sergio Carmona

Sergio Carmona

7

0 references

Martine Peeters

15

Martine Peeters

1 reference

14 October 2017

11

Pontiano Kaleebu

1 reference

14 October 2017

Michael R Jordan

1

1 reference

14 October 2017

Martina Penazzato

2

1 reference

14 October 2017

Amandine Cournil

3

1 reference

14 October 2017

Adolfo Vubil

4

1 reference

14 October 2017

Gillian Hunt

6

1 reference

14 October 2017

Gugu Maphalala

8

1 reference

14 October 2017

Nobuhle Mthethwa

9

1 reference

14 October 2017

Christine Watera

10

1 reference

14 October 2017

Christine Chakanyuka Musanhu

12

1 reference

14 October 2017

Janet Dzangare

14

1 reference

14 October 2017

Chunfu Yang

16

1 reference

14 October 2017

Neil Parkin

17

1 reference

14 October 2017

Silvia Bertagnolio

18

1 reference

14 October 2017

language of work or name

English

0 references

publication date

8 August 2017

1 reference

Clinical Infectious Diseases

14 October 2017

published in

1 reference

Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis

14 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX698

Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX698

Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX698

Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX698

World Health Organization generic protocol to assess drug-resistant HIV among children <18 months of age and newly diagnosed with HIV in resource-limited countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX698

Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX698

Short Communication: High Viral Load and Multidrug Resistance Due to Late Switch to Second-Line Regimens Could Be a Major Obstacle to Reach the 90-90-90 UNAIDS Objectives in Sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX698

High Rates of Drug Resistance Among Newly Diagnosed HIV-infected Children in the National Prevention of Mother-to-child Transmission Program in Togo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX698

Web resources for HIV type 1 genotypic-resistance test interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX698

The lymphocyte HIV reservoir in patients on long-term HAART is a memory of virus evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX698

HIV drug resistance mutations in proviral DNA from a community treatment program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX698

Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX698

Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX698

21 January 2018

Identifiers

DOI

10.1093/CID/CIX698

1 reference

14 October 2017

1 reference